Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.

Listen as he gives his perspectives on:

• Initial response to antiretroviral therapy during primary HIV infection with baseline resistance
• Data from the START study on treatment-naive patients with transmitted drug resistance by region and drug class
• Recommendations from the US Department of Health and Human Services and International AIDS Society–USA guidelines on baseline genotype testing for integrase strand transfer inhibitor resistance
• Considerations for the use of second-generation integrase strand transfer inhibitors and darunavir with transmitted drug resistance
• Cases of transmitted multidrug-resistant HIV in patients receiving pre-exposure prophylaxis

Presenter:
John D. Baxter, MD
Professor of Medicine
Division of Infectious Diseases
Department of Pathology
Cooper Medical School of Rowan University
Head, Division of Infectious Diseases
Cooper University Health Care
Camden, New Jersey

Follow along with the slides at:
https://bit.ly/3u7pjWq

See the entire program at: 
https://bit.ly/3fOl0XX